Bruce C. Cozadd
2012
In 2012, Bruce C. Cozadd earned a total compensation of $11.1M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 209% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,081,600 |
|---|---|
| Option Awards | $4,627,340 |
| Salary | $722,158 |
| Stock Awards | $4,682,990 |
| Other | $1,710 |
| Total | $11,115,798 |
Cozadd received $4.7M in stock awards, accounting for 42% of the total pay in 2012.
Cozadd also received $1.1M in non-equity incentive plan, $4.6M in option awards, $722.2K in salary and $1.7K in other compensation.
Rankings
In 2012, Bruce C. Cozadd's compensation ranked 347th out of 11,487 executives tracked by ExecPay. In other words, Cozadd earned more than 97.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 347 out of 11,487 | 97th |
Division Manufacturing | 130 out of 4,253 | 97th |
Major group Chemicals And Allied Products | 27 out of 1,198 | 98th |
Industry group Drugs | 14 out of 920 | 99th |
Industry Pharmaceutical Preparations | 11 out of 700 | 98th |
Source: SEC filing on June 10, 2015.
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2012.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019